[HTML][HTML] Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 …
Early Breast Cancer Trialists' Collaborative Group - The Lancet, 2011 - Elsevier
BACKGROUND: After breast-conserving surgery, radiotherapy reduces recurrence and
breast cancer death, but it may do so more for some groups of women than for others. We …
breast cancer death, but it may do so more for some groups of women than for others. We …
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients
JP Pignon, A Le Maitre, E Maillard, J Bourhis… - Radiotherapy and …, 2009 - Elsevier
BACKGROUND: Our previous individual patient data (IPD) meta-analysis showed that
chemotherapy improved survival in patients curatively treated for non-metastatic head and …
chemotherapy improved survival in patients curatively treated for non-metastatic head and …
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group
B Lacas, A Carmel, C Landais, SJ Wong… - Radiotherapy and …, 2021 - Elsevier
Abstract Background and purpose The Meta-Analysis of Chemotherapy in squamous cell
Head and Neck Cancer (MACH-NC) demonstrated that concomitant chemotherapy (CT) …
Head and Neck Cancer (MACH-NC) demonstrated that concomitant chemotherapy (CT) …
Internal mammary and medial supraclavicular lymph node chain irradiation in stage I–III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase …
PM Poortmans, C Weltens, C Fortpied… - The Lancet …, 2020 - thelancet.com
Background 10-year results from several studies showed improved disease-free survival
and distant metastasis-free survival, reduced breast cancer-related mortality, and variable …
and distant metastasis-free survival, reduced breast cancer-related mortality, and variable …
Internal mammary and medial supraclavicular irradiation in breast cancer
PM Poortmans, S Collette, C Kirkove… - … England Journal of …, 2015 - Mass Medical Soc
Background The effect of internal mammary and medial supraclavicular lymph-node
irradiation (regional nodal irradiation) added to whole-breast or thoracic-wall irradiation after …
irradiation (regional nodal irradiation) added to whole-breast or thoracic-wall irradiation after …
Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer
B Fisher, S Anderson, J Bryant… - … England Journal of …, 2002 - Mass Medical Soc
Background In 1976, we initiated a randomized trial to determine whether lumpectomy with
or without radiation therapy was as effective as total mastectomy for the treatment of invasive …
or without radiation therapy was as effective as total mastectomy for the treatment of invasive …
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group - The Lancet, 2005 - thelancet.com
Summary Background Quinquennial overviews (1985–2000) of the randomised trials in
early breast cancer have assessed the 5 year and 10-year effects of various systemic …
early breast cancer have assessed the 5 year and 10-year effects of various systemic …
[HTML][HTML] Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the …
Early Breast Cancer Trialists' Collaborative Group - The Lancet, 2005 - Elsevier
BACKGROUND: In early breast cancer, variations in local treatment that substantially affect
the risk of locoregional recurrence could also affect long-term breast cancer mortality. To …
the risk of locoregional recurrence could also affect long-term breast cancer mortality. To …
Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group
JP Pignon, H Tribodet, GV Scagliotti… - Journal of clinical …, 2008 - ascopubs.org
Purpose Several recent trials have shown a significant overall survival (OS) benefit from
postoperative cisplatin-based chemotherapy in patients with non–small-cell lung cancer …
postoperative cisplatin-based chemotherapy in patients with non–small-cell lung cancer …
Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of …
JS Cooper, Q Zhang, TF Pajak, AA Forastiere… - International Journal of …, 2012 - Elsevier
PURPOSE: Previous analysis of this Intergroup trial demonstrated that with a median follow-
up among surviving patients of 45.9 months, the concurrent postoperative administration of …
up among surviving patients of 45.9 months, the concurrent postoperative administration of …